Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4

Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme.

Roughly a year after disclosing plans to spin off Sandoz, Novartis says the separation of its generics and biosimilars business is set to take place on or around Oct. 4.